10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS.

Davies C., Pan H., Peto R.

DOI

10.1016/S0140-6736(17)31003-6

Type

Journal article

Publication Date

2017-05-13T00:00:00+00:00

Volume

389

Keywords

Antineoplastic Agents, Hormonal, Breast Neoplasms, Chemotherapy, Adjuvant, Humans, Receptors, Estrogen, Tamoxifen

Permalink More information Close